Seeing Is Believing
with an average price target of $1.64. This is a potential upside of $1.64 (0%) from yesterday's end of day stock price of $0.
Prevail Therapeutics's activity chart (see below) currently has 16 price targets and 14 ratings on display.
Analysts average stock forecasts to be materialized ratio is 68% with an average time for these price targets to be met of 199.2 days.
Most recent stock forecast was given by LAURA CHICO from WEDBUSH on 22-Dec-2020. First documented stock forecast 14-Jul-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$22
$-1 (-4.35%)
$22
4 years 10 months 2 days ago
(22-Dec-2020)
2/5 (40%)
$-1.18 (-5.09%)
234
Hold
$23
$23
4 years 10 months 8 days ago
(16-Dec-2020)
2/2 (100%)
$-0.17 (-0.73%)
84
Hold
$24
$1 (4.35%)
$24
4 years 10 months 10 days ago
(14-Dec-2020)
0/2 (0%)
$1.25 (5.49%)
Buy
5 years 2 months 14 days ago
(10-Aug-2020)
2/2 (100%)
$4.12 (25.94%)
241
Buy
$20
$-3 (-13.04%)
$20
5 years 9 months 28 days ago
(26-Dec-2019)
2/2 (100%)
$4.19 (26.50%)
437
What is PRVL (Prevail Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on PRVL (Prevail Therapeutics) with a proven track record?
Which analyst has the current lower performing score on PRVL (Prevail Therapeutics) with a proven track record?
Which analyst has the most public recommendations on PRVL (Prevail Therapeutics)?
Which analyst is the currently most bullish on PRVL (Prevail Therapeutics)?
Which analyst is the currently most reserved on PRVL (Prevail Therapeutics)?